What's new

Human medicines European public assessment report (EPAR): Ajovy, fremanezumab, Date of authorisation: 28/03/2019, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Ajovy, fremanezumab, Date of authorisation: 28/03/2019, Revision: 13, Status: Authorised

Apr 4, 2025 - 15:26
 0
Human medicines European public assessment report (EPAR): Ajovy, fremanezumab, Date of authorisation: 28/03/2019, Revision: 13, Status: Authorised
Human medicines European public assessment report (EPAR): Ajovy, fremanezumab, Date of authorisation: 28/03/2019, Revision: 13, Status: Authorised
Read More

Tags:

Previous Article

Elon Musk's 'Unprecedented Brand Damage' Means Tesla's Sales Drop Could Get A Lo...

Next Article

Human medicines European public assessment report (EPAR): Opsumit, macitentan, D...

Related Posts

Frequently asked questions

Frequently asked questions

Feb 20, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Adtralza, Tralokinumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Skin and subcutaneous tissue disorders, PIP number: P/0012/2024

Opinion/decision on a Paediatric investigation plan (PI...

Mar 14, 2025  0

Human medicines European public assessment report (EPAR): Xalkori, crizotinib, Date of authorisation: 23/10/2012, Revision: 37, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0